The latest market report published by Credence Research, Inc., the global market for electrodermal detecting devices is set to expand at CAGR by 8.7% from 2019 to 2027.
Electrodermal Activity Detection (EDA) is a methodology for understanding the different emotional and mood changes and the psychiatrist’s pattern for determining the treatment regimen accordingly. Double-function early diagnosis and monitoring of important physio-psychological parameters related to a sympathetic nervous system. The lies detectors used in the criminal investigation are formulated on the principle of galvanic skin response. Medical device manufacturers are developing wearable sensors that can measure the activities of the EDA at sites such as hand palms and leg soles.
Electrodermal activity detection is also known as galvanic skin response, which quantifies the measurement of changes in skin behavior associated with changes in emotional and mood patterns associated with a sympathetic nervous system. Psychological excitement is leading the application segment of the market for electrodermal activity detecting devices. Rising prevalence of mental illness and increasing demand for the development of novel technology to measure sudomotor nerve activity together drive market growth for psychological arousal. Physiological arousal are gathering tremendous attention among psychiatrist worldwide, on account of increasing demand to develop human machine interface to quantify the risk perception associated with workers safety and decision making process and consequently reducing the profession associated trauma and accident cases.
Browse the full report at https://www.credenceresearch.com/report/electrodermal-activity-detecting-devices-market
With a market share of 45% North America is in the driver’s seat for the regional segment of electrodermal activity detecting devices market. The chief attributing factors responsible for its global dominance are existence of developed medical device industry and increasing public health awareness pertaining to electrodermal activity detecting wearable devices in understanding mental health. Europe with a market share of 30% trails North America on account of strategic collaboration between medical device companies and academic research institutes in developing pertaining to electrodermal activity detecting devices. European Medical Agency (EMA), has adopted a proactive role in granting early CE approval for medical devices used in diagnosis and monitoring mental activities. Asia Pacific holds 15% market share owing to developing healthcare infrastructure and serves as a lucrative market opportunity for wearable EDA detecting devices to establish subsidiaries and retail outlets.
Medical device manufacturers competing in the electrodermal activity detecting devices market are BrainSigns, Srl, Eisco Labs, iMotions, Movisens GmbH, Maxim Integrated, PLUX Wireless Biosignals S.A., Shimmer and Vernier Software & Technology, LLC.
Key Market Movements:
- Rising public health awareness related to mental illness
- Significant rise in the human machine interface to understand emotional and other mood pattern at an early stage to determine treatment regimen accordingly
- Proactive policies adopted by global healthcare agencies by expediting the CE approval for electrodermal activity detection devices worldwide
Report Scope by Segments
By Application Type
- Physiological Arousal
- Psychological Arousal
- Perioperative Care
By Geography Segment
- North America (U.S., Rest of North America)
- Europe (U.K., Germany, France, Rest of Europe)
- Asia Pacific (China, Japan, India, Rest of Asia Pacific)
- Rest of the World (Middle East & Africa, Latin America)
Credence Research is providing Free Sample Get it here: https://www.credenceresearch.com/sample-request/59746